An2 Therapeutics, Inc. · NASDAQ:ANTX

Aziz Kabeer received 2,465 An2 Therapeutics, Inc. shares as an award (Form 4)

Traded Oct 12, 2026 · Filed Oct 13, 2026

On Oct 12, 2026, Aziz Kabeer (Director) received 2,465 An2 Therapeutics, Inc. shares as an award, leaving 61,571 shares. Filed Oct 13, 2026 (Form 4).

Awarded
2,465 shares
Holding after
61,571 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 12, 2026Common StockAward2,46561,571Direct

Source

View original at SEC

Related